Literature DB >> 12234513

Externally coated ureteral metallic stents: an unfavorable clinical experience.

George A Barbalias1, Evangelos N Liatsikos, Christina Kalogeropoulou, Dimitrios Karnabatidis, Petros Zabakis, Anastasios Athanasopoulos, Petros Perimenis, Dimitrios Siablis.   

Abstract

OBJECTIVE: The purpose of the present study was to evaluate the use of externally coated stents in patients with malignant ureteral obstruction.
MATERIALS AND METHODS: We have prospectively evaluated 16 patients, 10 men and 6 women, with malignant ureteral obstruction treated successfully by placement of Passager metal stents (Boston Scientific, Natick, MA, USA) bypassing the stricture. Mean patient age was 65.6 years (range 62-78 years). Ureteral patency was confirmed 24 and 48 hours by injection of contrast material through the nephrostomy tube, and after patency confirmation the nephrostomy catheter was removed.
RESULTS: All stents were positioned successfully, and the postoperative course was uneventful. In 13 cases (81.2%) the prostheses finally migrated into the bladder hindering overall ureteral patency (mean time of migration: 1.5 months). Patency was achieved in the remaining ureters (n=3), during the follow-up period (mean: 8 months, range 6-16 months), without any need for further intervention.
CONCLUSION: The inappropriate anchorage and the increased ureteral peristalsis are the main causes of migration towards the bladder, thus, minimizing the usefulness of this stent for the treatment of ureteral strictures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234513     DOI: 10.1016/s0302-2838(02)00281-6

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

Review 1.  Palliative management of malignant upper urinary tract obstruction.

Authors:  P Sountoulides; I Mykoniatis; N Dimasis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 2.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

3.  Resonance(®) metallic stent in patients with ureterocutaneostomies.

Authors:  S Proietti; M Sofer; A Giannantoni; L Luciani; G Taverna; G Giusti
Journal:  Int Urol Nephrol       Date:  2015-12-10       Impact factor: 2.370

4.  Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis.

Authors:  Udo Nagele; Markus A Kuczyk; Marcus Horstmann; Jörg Hennenlotter; Karl-Dietrich Sievert; David Schilling; Ute Walcher; Arnulf Stenzl; Aristotelis G Anastasiadis
Journal:  World J Urol       Date:  2008-03-07       Impact factor: 4.226

5.  Clinical experience with ureteral metal stents.

Authors:  Abdulrahman Al Aown; Kyriazis Iason; Kallidonis Panagiotis; Evangelos N Liatsikos
Journal:  Indian J Urol       Date:  2010-10

6.  Metal ureteral stents in chronic obstructions.

Authors:  Daniel Yachia
Journal:  Indian J Urol       Date:  2011-07

Review 7.  The effectiveness of ureteric metal stents in malignant ureteric obstructions: A systematic review.

Authors:  Panagiotis Kallidonis; Dimitrios Kotsiris; Francesco Sanguedolce; Panteleimon Ntasiotis; Evangelos Liatsikos; Athanasios Papatsoris
Journal:  Arab J Urol       Date:  2017-10-16

8.  Long-term outcomes of two types of metal stent for chronic benign ureteral strictures.

Authors:  Joongwon Choi; Kyung Jin Chung; Seol Ho Choo; Deok Hyun Han
Journal:  BMC Urol       Date:  2019-05-06       Impact factor: 2.264

9.  Palliative care of malignant ureteral obstruction with polytetrafluoroethylene membrane-covered self-expandable metallic stents: initial experience.

Authors:  Jae Han Kim; Kanghyon Song; Moon Ki Jo; Jong-Wook Park
Journal:  Korean J Urol       Date:  2012-09-19

10.  A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction.

Authors:  Jong Woo Kim; Bumsik Hong; Ji Hoon Shin; Jihong Park; Jin Hyoun Kim; Dong Il Gwon; Min-Hee Ryu; Baek-Yeol Ryoo
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.